Kabra Drugs Ltd

  • Market Cap 3.64 Cr.
  • Current Price 8.30
  • High & Low 8.30
  • Stock PE
  • Book Value 2.46
  • Dividend 0.00 %
  • ROCE -43.0 %
  • ROE -423 %
  • Face Value 10.0

About Kabra Drugs Ltd

Kabra Drugs Ltd is a prominent player in the industry, boasting a substantial market cap of ₹3.64 Crore. The current share price stands at ₹ 8.30, with the stock having fluctuated between 8.30 over the past year. The company's stock is priced at a P/E ratio of , indicating investor expectations of future growth.

Kabra Drugs Ltd's book value per share is ₹ 2.46, reflecting the company's net asset value. Despite a modest dividend yield of 0.00%, Kabra Drugs Ltd demonstrates strong profitability metrics with a Return on Capital Employed (ROCE) of -43.0% and a Return on Equity (ROE) of -423%. The face value of each share is ₹ 10.0, which is the nominal value of the stock.